Generic Drugs

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation
AMCP Caragon

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation